Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Net Income
Bottom-line profit after all expenses, interest, and taxes.
No reported Net Income figures are available to summarize.
Net Income history
Currency unavailable · from the income statement
No Net Income data reported for this period type.
Net Income vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $82.91M USD | +59.3% | — | 29.4% | |
| LTM Mar 2026 | -$26.79M USD | +81.0% | — | 11.5% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | -€46.27M EUR | -306.2% | — | — |
| LTM Mar 2026 | -$69.66M USD | +46.5% | — | 832.6% | |
| LTM Mar 2026 | -$104.29M USD | -8.2% | — | — | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | -$152.57M USD | -39.7% | — | — |
| LTM Sep 2026 | -$263.86M USD | -77.1% | — | 291.6% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | -$438.96M USD | -92.9% | — | 5933.5% |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -23.9% | — | 291.6% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.